News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
145–180
Matches
466
Sources here
18
Companies here
12
Search results Stored financial headlines

Active search

466 matching headlines

Ticker or company: VIVMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Vivakor's crude oil trading hits 2.4M barrels a...

Vivakor's subsidiary, Vivakor Supply & Trading, LLC, has secured new 12-month contracts to sell 200,000 barrels of West Texas Intermediate crude oil monthly, totaling 2.4 million barrels annually starting September 2026. This expansion brings Vivakor closer to $2 billion in annualized commercial activity, indicating …

VIVK main company
Sharemaestro market context Stored weekly price path 16 weeks -97.1% · Next-week setup negative 14.9% VIVK stored weekly price path from 1 May 2026 to 14 Aug 2026

VivoSim Labs (NASDAQ: VIVS) seeks approval for reverse split, warrant share issuance

VivoSim Labs (NASDAQ: VIVS) is seeking stockholder approval for several key proposals at its virtual 2026 annual meeting on September 30, 2026. These include electing Class III directors, ratifying their auditor, an advisory vote on executive compensation, and crucially, approving a board-discretionary reverse stock …

VIVS main company
Sharemaestro market context Price below Trend Line 52 weeks -84.7% · Next-week setup negative 38.4% VIVS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vivakor Accelerates Crude Oil Trading Portfolio toward $2 Billion in Annualized Commercial Activity

New 12-month transactions add 2.4 million barrels of annual sales volume Dallas, TX, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Vivakor, Inc. (Nasdaq: VIVK) ("Vivakor" or the "Company"), an integrated provider of energy transportation, storage, reuse and remediation services, today announced that its subsidiary, Vivakor …

VIVK main company
Sharemaestro market context Stored weekly price path 16 weeks -97.1% · Next-week setup negative 14.9% VIVK stored weekly price path from 1 May 2026 to 14 Aug 2026

200,000 barrels a month: Vivakor's new crude deals set to start Sept. 1

Vivakor (Nasdaq: VIVK) announced that its subsidiary, Vivakor Supply & Trading (VST), has secured new 12-month agreements to sell 200,000 barrels of WTI crude per month, totaling 2.4 million barrels annually. These transactions, starting September 1, 2026, and running through August 31, 2027, will …

VIVK main company
Sharemaestro market context Stored weekly price path 16 weeks -97.1% · Next-week setup negative 14.9% VIVK stored weekly price path from 1 May 2026 to 14 Aug 2026

Vivakor Inc (VIVK) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Vivakor Inc (VIVK), detailing its current stock price, market capitalization, and a list of peer companies for comparison. It highlights that the financial forecasting includes EPS, Revenue, Net Profit, and EBIT, with the data updated on August …

VIVK main company
Sharemaestro market context Stored weekly price path 16 weeks -97.1% · Next-week setup negative 14.9% VIVK stored weekly price path from 1 May 2026 to 14 Aug 2026

VIVS PE Ratio & Valuation, Is VIVS Overvalued

The article provides a valuation analysis of VivoSim Labs Inc (VIVS), indicating that the stock is currently in the "Fair zone" based on its forward PS ratio. It details various financial metrics such as Price-to-Book (P/B) ratio, Free Cash Flow (FCF) yield, and compares …

VIVS main company
Sharemaestro market context Price below Trend Line 52 weeks -84.7% · Next-week setup negative 38.4% VIVS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Does Innoviva’s Q2 Loss and Buyback-Fuled EPS Shift Change The Bull Case For INVA?

Innoviva, Inc. reported a Q2 2026 net loss of US$83.42 million despite increased revenue, leading to a loss per share of US$1.14 from continuing operations. This quarterly loss contrasts with strong first-half net income, creating a volatile earnings picture. The company's recent US$66.40 million …

INVA main company
Sharemaestro market context Price below Trend Line 52 weeks +5.1% · Next-week setup negative 42.4% INVA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vivid Seats Inc (SEAT) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Vivid Seats Inc (SEAT), noting its current earnings forecast score of 6.67 and ranking in the Software & IT Services industry. Analysts have a consensus price target of $13.50 for SEAT, with a "Hold" rating based on …

SEAT main company
Sharemaestro market context Trend signal active 52 weeks -57.7% · Next-week setup negative 44.6% SEAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Invivyd Inc (IVVD) Stock News Today

This article provides real-time stock information for Invivyd Inc (IVVD), including its current trading price, market cap, and recent performance. It also indicates that more news and analysis regarding the company will be available soon. The page serves as a hub for investors to …

IVVD main company
Sharemaestro market context Price below Trend Line 52 weeks +38.6% · Next-week setup negative 41.9% IVVD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Innoviva (INVA) Stock Can Revenue Growth Offset A Sharp Profit Reversal

Innoviva (INVA) stock saw a 2.9% increase despite a significant Q2 2026 profit reversal, swinging from a profit of US$63.7 million to a loss of US$83.4 million. The company's revenue, however, grew by 19% to US$119.6 million, driven by its Specialty Therapeutics portfolio and …

INVA main company
Sharemaestro market context Price below Trend Line 52 weeks +5.1% · Next-week setup negative 42.4% INVA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Telefonica Brasil SA (VIV) Stock News Today

This page provides current stock information for Telefonica Brasil SA (VIV), including its real-time stock price, market cap, and P/E ratio. It indicates that more news related to the company's stock, earnings, analyst ratings, and key developments will be available soon. The page serves …

VIV main company
Sharemaestro market context Price below Trend Line 52 weeks -3.9% VIV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Innoviva’s Q2 Loss and Aggressive Buybacks Could Reshape Capital Allocation for INVA Investors

Innoviva, Inc. reported mixed Q2 2026 results with increased revenue but a swing from net income to a significant net loss, while also completing a substantial share repurchase. This financial performance and capital allocation strategy may prompt investors to re-evaluate the company's investment narrative, …

INVA main company
Sharemaestro market context Price below Trend Line 52 weeks +5.1% · Next-week setup negative 42.4% INVA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Innoviva Inc (INVA) Stock News Today

This article provides current stock information for Innoviva Inc (INVA), including its stock price, market cap, and P/E TTM. It indicates that further news, earnings reports, analyst ratings, and key developments are anticipated to be published soon on the platform. The page primarily serves …

INVA main company
Sharemaestro market context Price below Trend Line 52 weeks +5.1% · Next-week setup negative 42.4% INVA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

VivoSim Labs, Inc. (VIVS) Stock Price, News, Quote & History

This article provides a comprehensive overview of VivoSim Labs, Inc. (VIVS) stock, including its real-time price, historical data, and key financial metrics. It details the company's profile as a biotechnology firm specializing in 3D human tissue models for drug testing and development. The report …

VIVS main company
Sharemaestro market context Price below Trend Line 52 weeks -84.7% · Next-week setup negative 38.4% VIVS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

VivoSim Labs Regains Nasdaq Compliance After $6M Milestone and $4M Financing

VivoSim Labs announced it has regained compliance with Nasdaq's minimum stockholders’ equity rule following a $5.0 million milestone payment from Eli Lilly, the release of $1.0 million from escrow, and a $4.0 million financing completed in July 2026. The company reported approximately $10.1 million …

VIVS main company
Sharemaestro market context Price below Trend Line 52 weeks -84.7% · Next-week setup negative 38.4% VIVS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

VIVO Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for VivoPower PLC (VIVO) stock, based on analyst opinions. It highlights that one analyst has a price target of $10.00, with a max and min estimate of $10.00. The article also includes current stock performance data, …

VIVO main company
Sharemaestro market context Trend signal active 52 weeks -4.5% VIVO stored weekly price path from 8 Aug 2025 to 14 Aug 2026

US$11.61 - That's What Analysts Think Vivid Seats Inc. (NASDAQ:SEAT) Is Worth After These Results

Vivid Seats Inc. (NASDAQ:SEAT) recently released its quarterly results, showing revenue of US$130m, 6.4% above forecasts, while statutory losses were in line with predictions at US$1.30 per share. Following these results, analysts anticipate 2026 revenues to be US$510.6m and foresee a significant reduction in …

SEAT main company
Sharemaestro market context Trend signal active 52 weeks -57.7% · Next-week setup negative 44.6% SEAT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vivani Medical Completes Enrollment, Dosing in Phase 1 SLIM-1 Trial

Vivani Medical announced the completion of enrollment and initial dosing for all 20 participants in its Phase 1 SLIM-1 trial. The trial is evaluating NPM-139, a long-acting semaglutide implant, for chronic weight management, focusing on its safety and tolerability.

VANI main company
Sharemaestro market context Trend signal active 52 weeks +12.9% · Next-week setup negative 42.2% VANI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Invivyd (IVVD) to Release Earnings on Thursday

Invivyd (IVVD) is scheduled to release its Q2 2026 earnings before market open on Thursday, August 13th, with analysts forecasting a loss of $0.15 per share and revenue of $14.4 million. The company's previous quarter missed expectations, and investor sentiment remains mixed, with a …

IVVD main company
Sharemaestro market context Price below Trend Line 52 weeks +38.6% · Next-week setup negative 41.9% IVVD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vivakor closes $12 million convertible note private placement

Vivakor Inc. (NASDAQ:VIVK) has successfully closed a $12 million convertible note private placement, securing $15 million in principal amount including the original issuance discount. The funds will be used to reduce debt, support working capital, advance its Houston Remediation Processing Center, and further its …

VIVK main company
Sharemaestro market context Stored weekly price path 16 weeks -97.1% · Next-week setup negative 14.9% VIVK stored weekly price path from 1 May 2026 to 14 Aug 2026

VivoSim Labs regains Nasdaq compliance after cash infusion

VivoSim Labs (NASDAQ:VIVS) has regained compliance with Nasdaq listing rules after receiving a $5.0 million milestone payment from Eli Lilly, a $1.0 million release from escrow, and completing a $4.0 million financing round. These financial infusions, which occurred in July 2026, increased the company's …

VIVS main company
Sharemaestro market context Price below Trend Line 52 weeks -84.7% · Next-week setup negative 38.4% VIVS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vivani Medical, Inc. (VANI) stock price, news, quote and history

Vivani Medical, Inc. (VANI) is a clinical-stage biopharmaceutical company focused on developing miniaturized subdermal drug implants for chronic diseases. The article provides a comprehensive overview of VANI's stock performance, including its current price, historical data, key financial metrics, and analyst ratings. It also details …

VANI main company
Sharemaestro market context Trend signal active 52 weeks +12.9% · Next-week setup negative 42.2% VANI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context